These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 32332015)
1. The Immunosuppressive Niche of Soft-Tissue Sarcomas is Sustained by Tumor-Associated Macrophages and Characterized by Intratumoral Tertiary Lymphoid Structures. Chen L; Oke T; Siegel N; Cojocaru G; Tam AJ; Blosser RL; Swailes J; Ligon JA; Lebid A; Morris C; Levin A; Rhee DS; Johnston FM; Greer JB; Meyer CF; Ladle BH; Thompson ED; Montgomery EA; Choi W; McConkey DJ; Anders RA; Pardoll DM; Llosa NJ Clin Cancer Res; 2020 Aug; 26(15):4018-4030. PubMed ID: 32332015 [TBL] [Abstract][Full Text] [Related]
2. Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13 Hu C; You W; Kong D; Huang Y; Lu J; Zhao M; Jin Y; Peng R; Hua D; Kuang DM; Chen Y Gastroenterology; 2024 Jun; 166(6):1069-1084. PubMed ID: 38445519 [TBL] [Abstract][Full Text] [Related]
3. Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review. Roulleaux Dugage M; Nassif EF; Italiano A; Bahleda R Front Immunol; 2021; 12():775761. PubMed ID: 34925348 [TBL] [Abstract][Full Text] [Related]
4. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer. Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485 [TBL] [Abstract][Full Text] [Related]
5. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. Chelvanambi M; Fecek RJ; Taylor JL; Storkus WJ J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33526609 [TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer. Sofopoulos M; Fortis SP; Vaxevanis CK; Sotiriadou NN; Arnogiannaki N; Ardavanis A; Vlachodimitropoulos D; Perez SA; Baxevanis CN Cancer Immunol Immunother; 2019 Nov; 68(11):1733-1745. PubMed ID: 31598757 [TBL] [Abstract][Full Text] [Related]
7. Intratumoral CXCL13 Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528 [TBL] [Abstract][Full Text] [Related]
8. The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas. Huang M; He M; Guo Y; Li H; Shen S; Xie Y; Li X; Xiao H; Fang L; Li D; Peng B; Liang L; Yu J; Kuang M; Xu L; Peng S Clin Cancer Res; 2020 Sep; 26(18):4947-4957. PubMed ID: 32527942 [TBL] [Abstract][Full Text] [Related]
9. Cancer Immunotherapies: From Efficacy to Resistance Mechanisms - Not Only Checkpoint Matters. Wang S; Xie K; Liu T Front Immunol; 2021; 12():690112. PubMed ID: 34367148 [TBL] [Abstract][Full Text] [Related]
11. A Systematic Review of the Tumor-Infiltrating CD8 Shadbad MA; Asadzadeh Z; Hosseinkhani N; Derakhshani A; Alizadeh N; Brunetti O; Silvestris N; Baradaran B Front Immunol; 2021; 12():734956. PubMed ID: 34603316 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in Sarcoma: Current Data and Promising Strategies. Wood GE; Meyer C; Petitprez F; D'Angelo SP Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432234. PubMed ID: 38781557 [TBL] [Abstract][Full Text] [Related]
13. Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma. Li H; Wang J; Liu H; Lan T; Xu L; Wang G; Yuan K; Wu H Aging (Albany NY); 2020 Feb; 12(4):3451-3472. PubMed ID: 32087064 [TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer. Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756 [TBL] [Abstract][Full Text] [Related]
15. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner. Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370 [TBL] [Abstract][Full Text] [Related]
16. The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade. Hildebrand KM; Singla AK; McNeil R; Marritt KL; Hildebrand KN; Zemp F; Rajwani J; Itani D; Bose P; Mahoney DJ; Jirik FR; Monument MJ PLoS One; 2021; 16(7):e0253864. PubMed ID: 34242269 [TBL] [Abstract][Full Text] [Related]
17. Identification and Characterization of Tertiary Lymphoid Structures in Murine Melanoma. Rodriguez AB; Peske JD; Engelhard VH Methods Mol Biol; 2018; 1845():241-257. PubMed ID: 30141017 [TBL] [Abstract][Full Text] [Related]
18. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. Goc J; Germain C; Vo-Bourgais TK; Lupo A; Klein C; Knockaert S; de Chaisemartin L; Ouakrim H; Becht E; Alifano M; Validire P; Remark R; Hammond SA; Cremer I; Damotte D; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC Cancer Res; 2014 Feb; 74(3):705-15. PubMed ID: 24366885 [TBL] [Abstract][Full Text] [Related]
19. High infiltration of B cells in tertiary lymphoid structures, TCR oligoclonality, and neoantigens are part of esophageal squamous cell carcinoma microenvironment. Barros LRC; Souza-Santos PT; Pretti MAM; Vieira GF; Bragatte MAS; Mendes MFA; De Freitas MV; Scherer NM; De Oliveira IM; Rapozo DCM; Fernandes PV; Simão TA; Soares-Lima SC; Boroni M; Ribeiro Pinto LF; Bonamino MH J Leukoc Biol; 2020 Oct; 108(4):1307-1318. PubMed ID: 32827331 [TBL] [Abstract][Full Text] [Related]
20. CD86 Wennhold K; Thelen M; Lehmann J; Schran S; Preugszat E; Garcia-Marquez M; Lechner A; Shimabukuro-Vornhagen A; Ercanoglu MS; Klein F; Thangarajah F; Eidt S; Löser H; Bruns C; Quaas A; von Bergwelt-Baildon M; Schlößer HA Cancer Immunol Res; 2021 Sep; 9(9):1098-1108. PubMed ID: 34155067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]